Literature DB >> 30606786

Convergence of risk prediction models in follicular lymphoma.

Anjali Silva1, Sleiman Bassim1, Clémentine Sarkozy2, Anja Mottok3, Tracy Lackraj1, Vindi Jurinovic4,5, Marianne Brodtkorb6, Ole Christian Lingjaerde6, Laurie H Sehn2, Randy D Gascoyne2, Oliver Weigert4, Christian Steidl2, Robert Kridel7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30606786      PMCID： PMC6545859          DOI： 10.3324/haematol.2018.209031

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Use of within-array replicate spots for assessing differential expression in microarray experiments.

Authors:  Gordon K Smyth; Joëlle Michaud; Hamish S Scott
Journal:  Bioinformatics       Date:  2005-01-18       Impact factor: 6.937

2.  Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis.

Authors:  Lee Mozessohn; Matthew C Cheung; Michael Crump; Rena Buckstein; Neil Berinstein; Kevin Imrie; John Kuruvilla; Eugenia Piliotis; Vishal Kukreti
Journal:  Leuk Lymphoma       Date:  2014-03-07

3.  FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

Authors:  Anja Mottok; Vindi Jurinovic; Pedro Farinha; Andreas Rosenwald; Ellen Leich; German Ott; Heike Horn; Wolfram Klapper; Michael Boesl; Wolfgang Hiddemann; Christian Steidl; Joseph M Connors; Laurie H Sehn; Randy D Gascoyne; Eva Hoster; Oliver Weigert; Robert Kridel
Journal:  Blood       Date:  2017-11-09       Impact factor: 22.113

4.  Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.

Authors:  Carla Casulo; Michelle Byrtek; Keith L Dawson; Xiaolei Zhou; Charles M Farber; Christopher R Flowers; John D Hainsworth; Matthew J Maurer; James R Cerhan; Brian K Link; Andrew D Zelenetz; Jonathan W Friedberg
Journal:  J Clin Oncol       Date:  2015-06-29       Impact factor: 44.544

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

7.  Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

Authors:  Matthew J Maurer; Emmanuel Bachy; Hervé Ghesquières; Stephen M Ansell; Grzegorz S Nowakowski; Carrie A Thompson; David J Inwards; Cristine Allmer; Catherine Chassagne-Clément; Emmanuelle Nicolas-Virelizier; Catherine Sebban; Laure Lebras; Clementine Sarkozy; William R Macon; Andrew L Feldman; Sergei I Syrbu; Alexandra Traverse-Glehan; Bertrand Coiffier; Susan L Slager; George J Weiner; Thomas E Witzig; Thomas M Habermann; Gilles Salles; James R Cerhan; Brian K Link
Journal:  Am J Hematol       Date:  2016-09-03       Impact factor: 10.047

8.  Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Authors:  Alessandro Pastore; Vindi Jurinovic; Robert Kridel; Eva Hoster; Annette M Staiger; Monika Szczepanowski; Christiane Pott; Nadja Kopp; Mark Murakami; Heike Horn; Ellen Leich; Alden A Moccia; Anja Mottok; Ashwini Sunkavalli; Paul Van Hummelen; Matthew Ducar; Daisuke Ennishi; Hennady P Shulha; Christoffer Hother; Joseph M Connors; Laurie H Sehn; Martin Dreyling; Donna Neuberg; Peter Möller; Alfred C Feller; Martin L Hansmann; Harald Stein; Andreas Rosenwald; German Ott; Wolfram Klapper; Michael Unterhalt; Wolfgang Hiddemann; Randy D Gascoyne; David M Weinstock; Oliver Weigert
Journal:  Lancet Oncol       Date:  2015-08-06       Impact factor: 41.316

Review 9.  Pathogenesis of follicular lymphoma.

Authors:  Tracy Lackraj; Rashmi Goswami; Robert Kridel
Journal:  Best Pract Res Clin Haematol       Date:  2017-11-01       Impact factor: 3.020

10.  A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

Authors:  Sarah Huet; Bruno Tesson; Jean-Philippe Jais; Andrew L Feldman; Laura Magnano; Emilie Thomas; Alexandra Traverse-Glehen; Benoit Albaud; Marjorie Carrère; Luc Xerri; Stephen M Ansell; Lucile Baseggio; Cécile Reyes; Karin Tarte; Sandrine Boyault; Corinne Haioun; Brian K Link; Pierre Feugier; Armando Lopez-Guillermo; Hervé Tilly; Pauline Brice; Sandrine Hayette; Fabrice Jardin; Fritz Offner; Pierre Sujobert; David Gentien; Alain Viari; Elias Campo; James R Cerhan; Gilles Salles
Journal:  Lancet Oncol       Date:  2018-02-20       Impact factor: 41.316
View more
  2 in total

1.  Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.

Authors:  Yu Zhou; Shasha Wang; Yunxia Tao; Haizhu Chen; Yan Qin; Xiaohui He; Shengyu Zhou; Peng Liu; Jianliang Yang; Sheng Yang; Lin Gui; Ning Lou; Zhishang Zhang; Jiarui Yao; Xiaohong Han; Yuankai Shi
Journal:  J Transl Med       Date:  2021-09-20       Impact factor: 5.531

2.  Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.

Authors:  Shinya Rai; Hiroaki Inoue; Kazuko Sakai; Hitoshi Hanamoto; Mitsuhiro Matsuda; Yasuhiro Maeda; Takahiro Haeno; Yosaku Watatani; Takahiro Kumode; Kentaro Serizawa; Yasuhiro Taniguchi; Chikara Hirase; J Luis Espinoza; Yasuyoshi Morita; Hirokazu Tanaka; Takashi Ashida; Yoichi Tatsumi; Kazuto Nishio; Itaru Matsumura
Journal:  Cancer Sci       Date:  2021-12-05       Impact factor: 6.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.